Valeant Pharmaceuticals International (VRX)

William Ackman · 2015-05

arc beats above · slides in the middle · loops below · scroll → 2 LOOPS

Deck intelligence map

coverage by narrative range · generated from this deck JSON

Narrative range 8 total

Metadata

Components

Metrics

Tools

Frameworks

Beats

Loops

Setup 1 slides 100% 1/1 slides 100% 1/1 slides · 5 hits

— 0/1 slides

100% 1/1 slides 100% 1/1 slides 100% 1/1 slides 100% 1/1 slides Evidence 6 slides 50% 3/6 slides 50% 3/6 slides · 15 hits

— 0/6 slides

33.3% 2/6 slides 50% 3/6 slides 100% 6/6 slides 50% 3/6 slides Summary 1 slides 100% 1/1 slides 100% 1/1 slides · 5 hits

— 0/1 slides

100% 1/1 slides

— 0/1 slides

100% 1/1 slides

— 0/1 slides

every slide · same image gating as the playbook

The slide uses a timeline-annotated line chart to correlate M&A activity with stock performance.illustrate_case

Open slide detailBeat · SetupLoop · Before After

establish_context

The chart uses a timeline-based annotation style to correlate corporate events with stock performance.summarize

Uses a qualitative scoring system (full circle, half circle) to assess Valeant against specific criteria.present_framework

Open slide detailBeat · EvidenceLoop · Benchmark Gap

The slide uses a valuation bridge format to justify the acquisition value creation.quantify_opportunity